Scandinavian Real Heart AB (Publ) logo

Scandinavian Real Heart AB (Publ) (7820)

Market Open
12 Aug, 13:26
XFRA XFRA
1. 64
-0.05
-2.9586%
2.71M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
1.69
Previous Close
Add Transaction
Day Range
1.64 1.7
Year Range
1.07 2.54
Want to track 7820 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7820 trading today lower at €1.64, a decrease of -2.9586% from yesterday's close, completing a monthly decrease of -2.0896% or -€0.04. Over the past 12 months, 7820 stock lost -29.9145%.
7820 is not paying dividends to its shareholders.
Scandinavian Real Heart AB (Publ) has completed 1 stock splits, with the recent split occurring on Nov 21, 2024.
The company's stock is traded on one exchange.

7820 Chart

People also search for

DCV
Advanex Inc.
13.2
-2.9412%
OKYO Pharma Limited
1.36
0%
78W
Modulight Oyj
1.04
-0.9524%
3NQ
Nano mRNA Co., Ltd.
0.55
0%
PGT
StrongPoint ASA
0.84
-0.4751%

Scandinavian Real Heart AB (Publ) (7820) FAQ

What is the stock price today?

The current price is €1.64.

On which exchange is it traded?

Scandinavian Real Heart AB (Publ) is listed on XFRA.

What is its stock symbol?

The ticker symbol is 7820.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.71M.

Has Scandinavian Real Heart AB (Publ) ever had a stock split?

Scandinavian Real Heart AB (Publ) had 1 splits and the recent split was on Nov 21, 2024.

Scandinavian Real Heart AB (Publ) Profile

Health Care Technology Industry
Healthcare Sector
Dr. Ina Laura Perkins CEO
XFRA Exchange
SE0023286836 ISIN
Sweden Country
15 Employees
- Last Dividend
21 Nov 2024 Last Split
- IPO Date

Overview

Scandinavian Real Heart AB (Publ) is a pioneering medical technology company based in Västerås, Sweden, primarily focused on the innovation and development of artificial heart solutions. Founded in 2007, their mission is to provide advanced treatments for patients suffering from severe heart failure. The company is at the forefront of creating artificial heart devices, leveraging cutting-edge technology to extend and improve the quality of life for individuals with heart conditions that are beyond conventional treatment methods.

Products and Services

Realheart TAH
Realheart TAH, or Total Artificial Heart, represents Scandinavian Real Heart AB's flagship development. This revolutionary product is designed for patients experiencing advanced-stage heart failure. It mimics the human heart's functionality, offering a promising solution for those in critical need of heart transplantation but facing the dire shortage of donor organs. It serves as a bridge to transplantation or as a long-term solution for those ineligible for a heart transplant.

RealVAD
The RealVAD system is a ventricular assist device focusing on supporting the left ventricle of the heart. This product is particularly beneficial for patients with left-sided heart failure, enhancing their heart's pumping capacity. RealVAD operates with a pulsating mechanism which closely resembles the natural heartbeat, thereby providing a more physiological approach to heart assistance.

PulsePump
PulsePump is an innovative device engineered for use with heart and lung machines during surgeries requiring cardiopulmonary bypass. It is designed to generate a pulsating flow that mimics the natural pulsation of blood through the human body. This feature is significant as it aims to reduce complications and improve outcomes for patients undergoing open-heart surgery by maintaining a more natural blood flow.

Sternal Prosthesis
Aiming to address the challenges associated with healing after open-chest surgery, Scandinavian Real Heart AB has developed a Sternal Prosthesis. This product is crucial for patients who have undergone surgeries that involve opening the sternum, as it provides a reliable method to secure and stabilize the chest wall during the critical healing period. This innovation not only improves patient recovery times but also significantly reduces the risk of post-operative complications associated with sternotomy procedures.

Contact Information

Address: Kopparbergsvägen 6
Phone: 46 2 14 75 55 50